HemaSphere
(Jun 2022)
P943: SURVIVAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA IN FRANCE: A COHORT STUDY USING THE FRENCH NATIONAL HEALTHCARE DATABASE (SNDS)
- X. Leleu,
- B. Gorsh,
- A. Bessou,
- P. Paka,
- J. De Nascimento,
- X. Colin,
- S. Landi,
- P. F. Wang
Affiliations
- X. Leleu
- 1 Department of Hematology, Centre Hospitalier Universitaire, Université de Poitiers, Poitiers, France
- B. Gorsh
- 2 GlaxoSmithKline, Upper Providence, PA, United States of America
- A. Bessou
- 3 IQVIA, Paris
- P. Paka
- 2 GlaxoSmithKline, Upper Providence, PA, United States of America
- J. De Nascimento
- 3 IQVIA, Paris
- X. Colin
- 4 GlaxoSmithKline, Rueil-Malmaison, France
- S. Landi
- 5 GlaxoSmithKline, Research Triangle Park, NC, United States of America
- P. F. Wang
- 2 GlaxoSmithKline, Upper Providence, PA, United States of America
- DOI
-
https://doi.org/10.1097/01.HS9.0000846640.89066.41
- Journal volume & issue
-
Vol. 6
pp.
833
– 834
WeChat QR code